Administrative bulletin: 2026-07-001 Updates and new information
Date: July 1, 2026
Topics covered in this administrative bulletin are applicable to:
Professional and facility Providers
- Evolent – High-tech radiology and cardiac imaging – Preauthorization and medical policy updates.
- NR-30.029 Services not Separately Reimbursed – Retirement and replacement with new consolidated policy and addition of new codes.
- New reimbursement policy – FP-01.011 Obstetrical Maternity Services.
- Preventive services health coverage guidelines — 2026 updates.
- Single source preauthorization list updates.
Professional Providers only
Unless otherwise noted, if you have any questions regarding the information in this bulletin, please contact your Provider Engagement Consultant or visit capbluecross.com/wps/portal/cap/provider/pec-look-up and enter your NPI or Tax ID to identify your designated point of contact at Capital Blue Cross.
Professional and facility Providers
Evolent – High-tech radiology and cardiac imaging – Preauthorization and medical policy updates
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: Effective August 1, 2026, Capital will sunset the delegation of high-tech radiology and cardiac imaging services through Evolent for the Medicare and CHIP lines of business.
- For CHIP, high-tech radiology and cardiac imaging services will no longer require preauthorization.
- For Medicare Advantage, most high-tech radiology and cardiac imaging services will no longer require preauthorization, with a few exceptions outlined below. For those exceptions, preauthorization and utilization management will transition to Capital effective August 1, 2026.
- For Commercial, high-tech radiology and cardiac imaging services will continue to require preauthorization through Evolent.
Effective August 1, 2026, the following policies will retire from the Medicare medical policy library.
Evolent Medicare Advantage policy retirements effective August 1, 2026 |
|
|---|---|
Procedure code |
Description |
|
Evolent CG 2002 |
Abdomen (CTA) |
|
Evolent CG 2005 |
Abdomen Pelvis (CTA) |
|
Evolent CG 2006 |
Abdominal Aorta (CTA) with Lower Extremity Runoff |
|
Evolent CG 2007 |
Bone Marrow (MRI) |
|
Evolent CG 2009 |
Brain (CTA) |
|
Evolent CG 2010 |
Magnetic Resonance Spectroscopy (MRS) |
|
Evolent CG 2015 |
Cerebral Perfusion (CT) |
|
Evolent CG 2020 |
Chest (CTA) |
|
Evolent CG 2022 |
Computed Tomography (CT) (Virtual) Colonoscopy – Diagnostic |
|
Evolent CG 2033 |
Lower Extremity (CTA) |
|
Evolent CG 2038 |
Magnetic Resonance Elastography (MRE) |
|
Evolent CG 2040 |
Neck (CTA) |
|
Evolent CG 2043 |
Pelvis (CTA) |
|
Evolent CG 2063 |
Upper Extremity (CTA) |
|
Evolent CG 2068 |
Brain and Neck (CTA) |
|
Evolent CG 7272 |
Coronary Artery Calcium Scoring by (EBCT) |
|
Evolent CG 7311 |
Multiple Gated Acquisition Scan (MUGA) |
|
Evolent CG 7312 |
Myocardial Perfusion Imaging (MPI) |
Effective August 1, 2026, the following procedure codes will no longer require preauthorization for Medicare Advantage and CHIP.
Preauthorization is no longer required for Medicare Advantage and CHIP effective August 1, 2026 |
|
|---|---|
Procedure code |
Description |
|
70336 |
MRI temporomandibular joint |
|
70450, 70460, 70470 |
CT head/brain |
|
70471 |
CT angiography, head and neck |
|
70473 |
Cerebral perfusion analysis CT |
|
70480, 70481, 70482 |
CT orbit |
|
70486, 70487, 70488 |
CT maxillofacial/sinus |
|
70490, 70491, 70492 |
CT soft tissue neck |
|
70496 |
CT angiography, head |
|
70498 |
CT angiography, neck |
|
70540, 70542, 70543 |
MRI orbit, face, neck and/or internal auditory canal |
|
70544, 70545, 70546 |
MRA head |
|
70547, 70548, 70549 |
MRA neck |
|
70551, 70552, 70553 |
MRI brain (with or without internal auditory canal views) |
|
70554, 70555 |
Functional MRI brain |
|
71250, 71260, 71270 |
CT chest |
|
71275 |
CT angiography, chest (non coronary) |
|
71550, 71551, 71552 |
MRI chest |
|
71555 |
MRA chest (excluding myocardium) |
|
72125, 72126, 72127 |
CT cervical spine |
|
72128, 72129, 72130 |
CT thoracic spine |
|
72131, 72132, 72133 |
CT lumbar spine |
|
72141, 72142, 72156 |
MRI cervical spine |
|
72146, 72147, 72157 |
MRI thoracic spine |
|
72148, 72149, 72158 |
MRI lumbar spine |
|
72159 |
MRA spinal canal |
|
72191 |
CT angiography, pelvis |
|
72192, 72193, 72194 |
CT pelvis |
|
72195, 72196, 72197 |
MRI pelvis |
|
72198 |
MRA pelvis |
|
73200, 73201, 73202 |
CT upper extremity |
|
73206 |
CT angiography, upper extremity |
|
73218, 73219, 73220 |
MRI upper extremity, other than joint |
|
73221, 73222, 73223 |
MRI upper extremity joint |
|
73225 |
MRA upper extremity |
|
73700, 73701, 73702 |
CT lower extremity |
|
73706 |
CT angiography, lower extremity |
|
73718, 73719, 73720, 73721, 73722, 73723 |
MRI lower extremity |
|
72195, 72196, 72197, 73721, 73722, 73723 |
MRI hip |
|
73725 |
MRA lower extremity |
|
74150, 74160, 74170 |
CT abdomen |
|
74175 |
CT angiography, abdomen |
|
74174 |
CT angiography, abdomen and pelvis |
|
74176, 74177, 74178 |
CT abdomen and pelvis combination |
|
74181, 74182, 74183 |
MRI abdomen (with or without MRCP) |
|
74185 |
MRA abdomen |
|
74261, 74262 |
Diagnostic CT colonoscopy (virtual colonoscopy, CT colonography) |
|
74712 |
Fetal MRI |
|
75557, 75559, 75561, 75563 |
MRI heart |
|
75571, S8092 |
Coronary artery CA score, heart scan, ultrafast CT heart, electron beam CT |
|
75572 |
CT heart |
|
75573 |
CT heart congenital studies, non-coronary arteries |
|
75635 |
CT angiography, abdominal aorta with lower extremity runoff |
|
76380 |
Follow up, limited or localized CT |
|
76390 |
MR spectroscopy |
|
76391 |
Magnetic resonance elastography (MRE) |
|
77046, 77047, 77048, 77049 |
MRI breast |
|
77084 |
MRI bone marrow |
|
78472, 78473, 78494 |
Muga scan |
|
78608, 78609 |
PET scan, brain |
|
78803, 78830, 78831, 78832 |
Radiopharmaceutical tumor localization (SPECT) |
|
78811, 78812, 78813, 78814, 78815, 78816 |
PET scan |
|
78811, 78812, 78813, 78814, 78815, 78816 |
PET scan with concurrently acquired CT for attenuation correction and anatomic localization. |
|
93303, 93304, 93306, 93307, 93308 |
Transthoracic echocardiography (TTE) |
|
93312, 93313, 93314, 93315, 93316, 93317, 93318 |
Transesophageal echocardiography (TEE) |
|
G0219 |
Pet imaging, whole body, melanoma for non-covered indications |
|
G0252 |
Pet imaging, initial diagnosis of breast cancer and/or surgical planning for breast cancer |
Effective August 1, 2026, the following services will require preauthorization through Capital for Medicare Advantage. They will no longer require preauthorization for CHIP.
Preauthorization is required for Medicare Advantage through Capital |
|
|---|---|
Procedure code |
Description |
|
78459, 78491, 78492, 78429, 78430, 78431, 78432, 78433 |
Heart PET scan with CT for attenuation |
|
78451, 78452, 78453, 78454, 78466, 78468, 78469, 78481, 78483, 78499 |
Myocardial perfusion imaging |
|
78459, 78491, 78492 |
Heart PET scan |
|
93350, 93351 |
Stress echocardiography |
A complete list of CPT/HCPCS codes requiring preauthorization can be found on Capital's Single source preauthorization list.
NR-30.029 Services not Separately Reimbursed – Retirement and replacement with new consolidated policy and addition of new codes
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: The Network Policy NR-30.029 Services Not Separately Reimbursed will be retired effective August 31, 2026. A new policy, FP-01.008 Services Not Separately Reimbursed, will be implemented effective September 1, 2026. New codes are added to the policy that will no longer be separately reimbursed effective September 1, 2026.
This policy transition adds new codes to the policy and consolidates existing guidance into a single, comprehensive policy that applies to both Facility and Professional providers.
Effective September 1, 2026, Capital Blue Cross will no longer reimburse for the following codes for Commercial.
Procedure code |
Description |
|---|---|
|
99374 |
Supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (e.g., Alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (e.g., legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 15-29 minutes. |
|
99375 |
Supervision of a patient under care of home health agency (patient not present) in home, domiciliary or equivalent environment (e.g., Alzheimer's facility) requiring complex and multidisciplinary care modalities involving regular development and/or revision of care plans by that individual, review of subsequent reports of patient status, review of related laboratory and other studies, communication (including telephone calls) for purposes of assessment or care decisions with health care professional(s), family member(s), surrogate decision maker(s) (e.g., legal guardian) and/or key caregiver(s) involved in patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month; 30 minutes or more. |
|
G0179 |
Physician or allowed practitioner re-certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care. |
|
G0180 |
Physician or allowed practitioner certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians or allowed practitioners to affirm the initial implementation of the plan of care. |
|
G0181 |
Physician or allowed practitioner supervision of a patient receiving Medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans. |
|
G0574 |
Management of new patient with dementia residing in an eligible residential care community, for use only in a Medicare-approved CMMI Model (Services must be furnished within a patient's eligible residential care community, including assisted living facilities, board and care homes, or other qualifying residential settings where dementia care services are provided). |
|
G0575 |
Management of established patient with dementia residing in an eligible residential care community, for use only in a Medicare-approved CMMI Model (Services must be furnished within a patient's eligible residential care community, including assisted living facilities, board and care homes, or other qualifying residential settings where dementia care services are provided). |
|
G0669 |
Outcome-aligned payment (OAP) for technology-enabled chronic care management of early cardio-kidney-metabolic (ECKM) conditions (hypertension, or two or more of: dyslipidemia, obesity/overweight with central obesity marker, prediabetes); Initial 12-Month Period; per month. |
|
G0670 |
Outcome-aligned payment (OAP) for technology-enabled chronic care management of early cardio-kidney-metabolic (ECKM) conditions (hypertension, or two or more of: dyslipidemia, obesity/overweight with central obesity marker, prediabetes); Follow-on 12-Month Period; per month. |
|
G0671 |
Outcome-aligned payment (OAP) for technology-enabled chronic care management of cardio-kidney-metabolic (CKM) conditions (one or more of: diabetes mellitus, chronic kidney disease stage 3A or 3B, atherosclerotic cardiovascular disease); Initial 12-Month Period; per month. |
|
G0672 |
Outcome-aligned payment (OAP) for technology-enabled chronic care management of cardio-kidney-metabolic (CKM) conditions (one or more of: diabetes mellitus, chronic kidney disease stage 3A or 3B, atherosclerotic cardiovascular disease); Follow-on 12-Month Period; per month. |
|
G0673 |
Outcome-aligned payment (OAP) for technology-enabled chronic care management of musculoskeletal (MSK) conditions (chronic musculoskeletal pain); initial 12-Month Treatment Period; per month. |
|
G0676 |
Standard co-management service payment for documented review of clinical updates from access participant managing cardio-kidney-metabolic conditions (early cardio-kidney-metabolic (ECKM) or cardio-kidney-metabolic (CKM) track); per review. |
|
G0677 |
Standard co-management service payment for documented review of clinical updates from access participant managing musculoskeletal (MSK) conditions; per review. |
Effective September 1, 2026, Capital Blue Cross will no longer reimburse for the following codes for Commercial and Medicare Advantage.
Procedure code |
Description |
|---|---|
|
69209 |
Removal of impacted cerumen using irrigation/lavage, unilateral. |
|
76376 |
3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation. |
|
76377 |
3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstation. |
New reimbursement policy – FP-01.011 Obstetrical Maternity Services
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: Capital Blue Cross has created reimbursement policy FP-01.011 – Obstetrical Maternity Services that will go into effect on September 1, 2026, preparing providers for CPT® coding changes for 2027, transitioning away from global obstetric codes in favor of visit-based service reporting.
Overview of Changes:
Prior to September 1, 2026, (global-based billing) – Patients presenting for their first prenatal visit after the confirmation of pregnancy will continue to use bundled codes:
- 59425 (Antepartum care only; 4-6 visits)
- 59426 (Antepartum care only; 7 or more visits)
On or after September 1, 2026, (visit/service based billing) – Patients presenting for their first prenatal visit after confirmation of pregnancy will require the use of:
- Evaluation and management (E/M) codes with the HCPCS modifier “TH" – Obstetrical treatment/services, prenatal or postpartum.
- Claims must include the appropriate ICD-10-CM codes, including the weeks of gestation Z3A.XX. (“XX” defines week of gestation. I.e., Z3A.15 equals 15 weeks gestation.)
- Documentation must support medical decision-making or time consistent with current CPT guidelines.
The E/M level reported should reflect the service provided during the encounter, considering the presenting problem, the amount and/or complexity of data reviewed, and the risk of complications and/or morbidity or mortality associated with patient management. The “TH" modifier appended to the E/M code will differentiate the visit as related to the prenatal or postpartum visit. Providers are responsible for ensuring that documentation accurately reflects the patient's severity and the services rendered.
Reimbursement Policy FP-01.011 also addresses the following obstetrics and maternity services transitioning from global-based billing to visit/service-based billing effective January 1, 2027.
- Labor management – Codes (e.g., 59080-59083, 59030, and 59051) are used to report interim physical examinations, the collection and interpretation of physiologic data, and the induction or augmentation of labor. The initial day of labor management may be reported once per facility admission unless services are provided by a different provider. A face‑to‑face encounter is required and may be billed once per calendar date. Multiple visits by the same physician or qualified health care professional (QHP) within the same setting on a single calendar date must be reported as a single labor management service. A continuous encounter that spans two calendar dates should be reported as one service on either of the two dates.
- Delivery care – Codes (e.g., 59431-59504) are used once labor has been completed or interrupted and may be reported on the same day as initial or subsequent labor management services, even when both services are provided by the same physician or qualified health care professional.
- Postpartum care – Use codes (e.g., 59623, 59610, 59350) appended to E/M codes. Routine postpartum care provided on the same calendar date as the delivery is not separately reportable; it is included in the delivery care code. For a facility birth, postpartum care may be billed using the appropriate subsequent hospital care E/M codes for each management day until discharge, as well as the applicable discharge day management codes.
Preventive services health coverage guidelines — 2026 updates
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: Effective July 1, 2026, the following updates have been made to the Preventive Services Health Coverage Guidelines.
The July 2026 guidelines were updated to include the following:
Preventive service(s) |
Action |
Highlights |
|---|---|---|
|
CONTRACEPTIVE DEVICES/SUPPLIES |
Revised |
Revised procedure codes to include J7299. |
To ensure preventive services for members are covered with no cost-share when applicable, Providers are reminded to reference the Preventive Services Health Coverage Guidelines via our provider portal (Availity Essentials). They can be accessed by selecting the Resources tab > Provider Library > Education and manuals > under the Guidelines dropdown menu.
Single source preauthorization list updates
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: Updates to the Single Source preauthorization list will occur as described below.
Effective August 1, 2026, the following procedure code(s) will not require preauthorization for Commercial and Medicare Advantage.
Commercial and Medicare Advantage effective August 1, 2026 |
|
|---|---|
Code |
Description |
|
V2785 |
Processing, preserving, and transporting corneal tissue |
Effective September 1, 2026, the following procedure code(s) will require preauthorization for Medicare Advantage.
Medicare Advantage effective September 1, 2026 |
|
|---|---|
Code |
Description |
|
J1577 |
Injection, immune globulin-kthm (Qivigly), 100mg |
|
J3405 |
Injection, onasemnogene abeparvovec-brve, per treatment |
|
J1289 |
Injection, narsoplimab-wuug (Yartemlea) |
|
J9053 |
Injection, belantamab mafodotin-blmf (Blenrep) |
|
J9067 |
Injection, amivantamab and hyaluronidase-lpju (Rybrevant Faspro) |
|
Q5165 |
Injection, denosumab-mobz (Oziltus), biosimilar, 1mg |
|
Q5171 |
Injection, denosumab-mobz (Boncresa), biosimilar, 1mg |
|
Q5166 |
Injection, denosumab-desu (Osyvrti/Jubereq), biosimilar, 1mg |
|
Q5167 |
Injection, denosumab-qbde (Enoby/Xtrenbo), biosimilar, 1mg |
|
J2361 |
Injection, depemokimab-ulaa (Exdensur) |
|
Q5168 |
Injection, ranibizumab-leyk (Nufymco), biosimilar, 0.1mg |
|
Q5169 |
Injection, pegfilgrastim-unne (Armlupeg), biosimilar, 0.5mg |
|
Q5170 |
Injection, aflibercept-boav (Eydenzelt), biosimilar, 1mg |
Effective immediately upon release from the drug manufacturer, the following procedure code(s) will require preauthorization for Medicare Advantage and Commercial.
Commercial and Medicare Advantage effective immediately upon release |
|
|---|---|
Code |
Description |
|
J3386 |
Injection, Etuvetidigene Autotemcel (Waskyra), per treatment |
Note: Codes that require preauthorization are maintained on the Capital Blue Cross Single source preauthorization list located on Capital’s provider web page.
Professional Providers only
Expanded reimbursement for rabies vaccine 90675 in urgent care settings
- CHIP
- EPO
- FEP PPO
- HMO
- Medicare Advantage HMO
- POS
- PPO
- Traditional and Comprehensive
- Medicare Advantage PPO
KEY POINT: Rabies Vaccine 90675 is now eligible for reimbursement in an Urgent Care setting.
Effective May 22, 2026, providers in Urgent Care settings can receive separate reimbursement for rabies vaccine CPT code 90675. Historically, reimbursement for CPT 90675 was bundled into the global payment rate associated with Urgent Care services.
It is important to note that while reimbursement methodology has changed, all existing billing and documentation requirements remain unchanged. Providers should continue to follow current guidelines to ensure accurate coding, compliance, and proper claim processing.